Evolent Health, Inc. (NYSE:EVH) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders
of stockholders on June 8, 2017. At the 2017 annual meeting, the
Companys stockholders voted on two proposals. The proposals are
described in the Companys definitive proxy statement on Schedule
14A for the 2017 annual meeting filed with the Securities and
Exchange Commission on April 27, 2017. As of the record date of
April 18, 2017, there were 57,040,976 shares of Class A common
stock and 10,948,832 shares of Class B common stock (each entitled
to one vote per share) outstanding and entitled to vote at the 2017
annual meeting.
upon at the 2017 annual meeting are set forth below.
the holders of our Class A common stock and Class B common stock,
voting together as one class, each of the three Class II director
nominees named in the proxy statement to the Board of Directors for
a three-year term expiring at the Companys 2020 annual meeting of
stockholders and until their respective successors are duly elected
and qualified, as set forth below:
|
|
|
|
|
|
|
|
Broker
|
||||
|
|
For
|
|
Against
|
|
Abstentions
|
|
Non-Votes
|
||||
|
Matthew Hobart
|
44,261,297
|
|
|
7,572,993
|
|
|
|
|
4,991,820
|
|
|
|
Diane Holder
|
37,141,379
|
|
14,692,270
|
|
1,261
|
|
4,991,820
|
||||
|
Michael D’Amato
|
45,046,573
|
|
|
6,787,917
|
|
|
|
|
4,991,820
|
|
PricewaterhouseCoopers LLP as the Companys independent registered
public accounting firm for the Companys fiscal year ending
December 31, 2017, by the affirmative vote of a majority of votes
cast by the holders of our Class A common stock and Class B
common stock, voting together as one class, as set forth below:
|
|
|
|
|
|
|
Broker
|
||||
|
For
|
|
Against
|
|
Abstentions
|
|
Non-Votes
|
||||
|
56,794,394
|
|
|
22,371
|
|
|
9,965
|
|
|
|
About Evolent Health, Inc. (NYSE:EVH)
Evolent Health, Inc. supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services. Together these services enable health systems to manage patients’ health. It provides an end-to-end, built-for-purpose, technology-enabled services platform for providers in value-based payment models. Its platform supports a diverse set of provider value-based care strategies. It provides the technology and services necessary for the models pursued by providers. The Company offers Identifi, a technology platform that aggregates and analyzes data, manages care workflows and engages patients. Its Value-Based Operations are empowered and supported by Identifi.